Core needle biopsy accuracy varies by lymphoma subtype. Which one yields the highest diagnostic sensitivity? Test your knowledge of hematologic pathology.
With the approval of resmetirom and GLP-1 receptor agonists showing promise as a potential treatment option, the management of metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving....
With the approval of resmetirom and GLP-1 receptor agonists showing promise as a potential treatment option, the management of metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving....
With the approval of resmetirom and GLP-1 receptor agonists showing promise as a potential treatment option, the management of metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving....
With the approval of resmetirom and GLP-1 receptor agonists showing promise as a potential treatment option, the management of metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving....
A recent systematic review identifies key barriers and emphasizes the need for psychologically safe, culturally informed dialogue about menopause across all settings. Take this quiz to test your...
A recent systematic review identifies key barriers and emphasizes the need for psychologically safe, culturally informed dialogue about menopause across all settings. Take this quiz to test your...
A recent systematic review identifies key barriers and emphasizes the need for psychologically safe, culturally informed dialogue about menopause across all settings. Take this quiz to test your...
With the approval of the first anti-amyloid antibodies, lecanemab and donanemab, the therapeutic landscape for Alzheimer disease has entered a new era—one that presents both promise and complexity. This...
With the approval of the first anti-amyloid antibodies, lecanemab and donanemab, the therapeutic landscape for Alzheimer disease has entered a new era—one that presents both promise and complexity. This...
